Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Empagliflozin Evaluation by Measuring Impact on Hemodynamics in Patients With Heart Failure

Trial Profile

Empagliflozin Evaluation by Measuring Impact on Hemodynamics in Patients With Heart Failure

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Dec 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Empagliflozin (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms EMBRACE-HF
  • Most Recent Events

    • 10 Nov 2021 Status changed from active, no longer recruiting to completed.
    • 18 Mar 2021 Planned End Date changed from 30 Jan 2021 to 30 Apr 2021.
    • 08 Feb 2021 Primary endpoint has been met. (To compare the change in pulmonary artery diastolic pressure from baseline to end of treatment period between empagliflozin and placebo), as per Results published in the Circulation
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top